Race is associated with discontinuation of active surveillance of low-risk prostate cancer: Results from the Duke Prostate Center

被引:67
作者
Abern, M. R.
Bassett, M. R.
Tsivian, M.
Banez, L. L.
Polascik, T. J.
Ferrandino, M. N.
Robertson, C. N.
Freedland, S. J.
Moul, J. W. [1 ,2 ]
机构
[1] Duke Univ, Med Ctr, Dept Surg, Div Urol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Duke Canc Inst, Duke Prostate Ctr, Durham, NC 27710 USA
关键词
prostate adenocarcinoma; active surveillance; race; BIOCHEMICAL DISEASE RECURRENCE; AFRICAN-AMERICAN; RADICAL PROSTATECTOMY; SOCIOECONOMIC-STATUS; RACIAL-DIFFERENCES; WHITE MEN; SURVIVAL; IMPACT; ACCESS; TIME;
D O I
10.1038/pcan.2012.38
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Active surveillance (AS) is increasingly utilized in low-risk prostate cancer (PC) patients. Although black race has traditionally been associated with adverse PC characteristics, its prognostic value for patients managed with AS is unclear. METHODS: A retrospective review identified 145 patients managed with AS at the Duke Prostate Center from January 2005 to September 2011. Race was patient-reported and categorized as black, white or other. Inclusion criteria included PSA <10 ng ml(-1), Gleason sum <= 6, and <= 33% of cores with cancer on diagnostic biopsy. The primary outcome was discontinuation of AS for treatment due to PC progression. In men who proceeded to treatment after AS, the trigger for treatment, follow-up PSA and biopsy characteristics were analyzed. Time to treatment was analyzed with univariable and multivariable Cox proportional hazards models and also stratified by race. RESULTS: In our AS cohort, 105 (72%) were white, 32 (22%) black and 8 (6%) another race. Median follow-up was 23.0 months, during which 23% percent of men proceeded to treatment. The demographic, clinical and follow-up characteristics did not differ by race. There was a trend toward more uninsured black men (15.6% black, 3.8% white, 0% other, P = 0.06). Black race was associated with treatment (hazard ratio (HR) 2.93, P = 0.01) as compared with white. When the analysis was adjusted for socioeconomic and clinical parameters at the time of PC diagnosis, black race remained the sole predictor of treatment (HR 3.08, P = 0.01). Among men undergoing treatment, the trigger was less often patient driven in black men (8 black, 33 white, 67% other, P = 0.05). CONCLUSIONS: Black race was associated with discontinuation of AS for treatment. This relationship persisted when adjusted for socioeconomic and clinical parameters. Prostate Cancer and Prostatic Disease (2013) 16, 84-89; doi:10.1038/pcan.2012.38; published online 16 October 2012
引用
收藏
页码:84 / 89
页数:6
相关论文
共 37 条
[1]   Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy [J].
Amling, CL ;
Riffenburgh, RH ;
Sun, L ;
Moul, JW ;
Lance, RS ;
Kusuda, L ;
Sexton, WJ ;
Soderdahl, DW ;
Donahue, TF ;
Foley, JP ;
Chung, AK ;
McLeod, DG .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) :439-445
[2]  
[Anonymous], CANCER
[3]   Race and Time from Diagnosis to Radical Prostatectomy: Does Equal Access Mean Equal Timely Access to the Operating Room?-Results from the SEARCH Database [J].
Banez, Lionel L. ;
Terris, Martha K. ;
Aronson, William J. ;
Presti, Joseph C., Jr. ;
Kane, Christopher J. ;
Amling, Christopher L. ;
Freedland, Stephen J. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (04) :1208-1212
[4]   Racial variation in the pattern and quality of care for prostate cancer in the USA: mind the gap [J].
Barocas, Daniel A. ;
Penson, David F. .
BJU INTERNATIONAL, 2010, 106 (03) :322-328
[5]  
Barrett William L, 2004, Brachytherapy, V3, P30, DOI 10.1016/j.brachy.2003.11.003
[6]   Methods of calculating prostate-specific antigen velocity [J].
Connolly, David ;
Black, Amanda ;
Murray, Liam J. ;
Napolitano, Giulio ;
Gavin, Anna ;
Keane, Patrick F. .
EUROPEAN UROLOGY, 2007, 52 (04) :1044-1051
[7]   Racial/Ethnic Patterns in Prostate Cancer Outcomes in an Active Surveillance Cohort [J].
Cullen, Jennifer ;
Brassell, Stephen A. ;
Chen, Yongmei ;
Porter, Christopher ;
L'Esperance, James ;
Brand, Timothy ;
McLeod, David G. .
PROSTATE CANCER, 2011, 2011
[8]   Active surveillance for the management of prostate cancer in a contemporary cohort [J].
Dall'Era, Marc A. ;
Konety, Badrinath R. ;
Cowan, Janet E. ;
Shinohara, Katsuto ;
Stauf, Frank ;
Cooperberg, Matthew R. ;
Meng, Maxwell V. ;
Kane, Christopher J. ;
Perez, Nanette ;
Master, Viraj A. ;
Carroll, Peter R. .
CANCER, 2008, 112 (12) :2664-2670
[9]   A Multi-institutional Evaluation of Active Surveillance for Low Risk Prostate Cancer [J].
Eggener, Scott E. ;
Mueller, Alex ;
Berglund, Ryan K. ;
Ayyathurai, Raj ;
Soloway, Cindy ;
Soloway, Mark S. ;
Abouassaly, Robert ;
Klein, Eric A. ;
Jones, Steven J. ;
Zappavigna, Chris ;
Goldenberg, Larry ;
Scardino, Peter T. ;
Eastham, James A. ;
Guillonneau, Bertrand .
JOURNAL OF UROLOGY, 2009, 181 (04) :1635-1641
[10]   Explaining racial differences in prostate cancer in the United States: Sociology or biology? [J].
Freedland, SJ ;
Isaacs, WB .
PROSTATE, 2005, 62 (03) :243-252